Emerging and reemerging intestinal protozoa

Current Opinion in Gastroenterology

Volumn 17, Issue 1, 2001, Pages 17-23

  Huston, Christopher D ^a,b   Petri Jr , William A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b MR 4 Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIRETROVIRUS AGENT; AZITHROMYCIN; CIPROFLOXACIN; COTRIMOXAZOLE; METRONIDAZOLE; NITAZOXANIDE; PAROMOMYCIN; RIFABUTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMEBIASIS; CLINICAL FEATURE; CLINICAL TRIAL; COCCIDIOSIS; CRYPTOSPORIDIOSIS; CYCLOSPORA CAYETANENSIS; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; ECONOMIC ASPECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FECES ANALYSIS; HIGH RISK POPULATION; HUMAN; INTESTINE INFECTION; ISOSPORA BELLI; MICROSPORIDIOSIS; ORGAN TRANSPLANTATION; PARASITE IDENTIFICATION; PROTOZOAL INFECTION; REVIEW; TREATMENT OUTCOME;

EID: 0035143217     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200101000-00004     Document Type: Review

References (73)

1. Occurrence of Giardia and Cryptosporidium spp. in surface water supplies
2. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS
3. Cryptosporidium sp
4. A sporozoan found in the peptic glands of the common mouse
5. Acute enterocolitis in a human being infected with the protozoan Cryptosporidium
6. Overwhelming watery diarrhea associated with a Cryptosporidium in an immunosuppressed patient
7. Human cryptosporidiosis in immunocompetent and immunodeficient persons: Studies of an outbreak and experimental transmission
8. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply
9. Cryptosporidiosis in child care settings: A review of the literature and recommendations for prevention and control
10. Cryptospondiosis in hospital personnel
11. Declining CD4+ T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: Results of a 3-year longitudinal study
12. Intestinal parasites in patients with diarrhea and human immunodeficiency virus infection in Zimbabwe
13. Intestinal protozoa in HIV-infected patients in Apulia, South Italy
14. Emerging and opportunistic intestinal parasites in HIV-infected patients with chronic diarrhea in Rio de Janeiro, Brazil
15. Diagnosis of Cryptosporidium parvum in patients with severe diarrhea and AIDS
16. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptcaporidium parvum in human fecal specimens
17. Fatse-positive results obtained with the Alexon ProSpec T cryptosporidium enzyme immunoassay
18. False-positive laboratory tests for cryptosporidium involving an enzyme-linked immunosorbent assay: United States, November 1997-March 1998
19. Timing of symptoms and oocyst excretion in human cryptosporidiosis
20. Improvement of chronic diarrhea in patients with advanced HIV-1 infection during potent antiretroviral therapy
21. Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1
22. Prospective trial of paromomycin for cryptosporidiosis in AIDS
23. Paromomycin: An effective treatment for cryptosporidial diarrhea in patients with AIDS
24. Paromomycin treatment against cryptosporidiosis in patients with AIDS
25. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models
26. Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture
27. A double-blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhea in AIDS patients in Mexico
28. Isospora belli, Sarcocystis Species, Blastocysti, S. hominis, and Cyclospora
29. Intractable diarrhea of infancy due to intestinal coccidiosis
30. Clinical manifestations and therapy of Isosoora belli infection in patients with acquired immunodeficiency syndrome
31. Treatment and prophylaxis of Isospora belli infection in patients with acquired immunodeficiency syndrome
32. Isosoora belli infections in patients with human T-cell leukemia virus type 1-associated adult T-cell leukemia
33. AIDS enteropathy
34. Cryptosporidium and Isospora belli infections
35. Fuonsin fluorescence and autofluorescence in Cryptosporidium. Isospora and Cyclospora oocysts
36. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients a randomized, controlled trial
37. An outbreak in 1996 of cyclosporiasis associated with imported raspberries
38. Cyclosporiasis associated with imported raspberries, Florida, 1996
39. Outbreak of cyclosporiasis United States and Canada
40. Microsporidiosis
41. Prevalence and clinical significance of intestinal microsporidiosis in human immunodeficiency virus-infected patients with and without diarrhea in Germany: A prospective coprodiagnostic study
42. Intestinal microsporidiosis occuring in a liver transplant recipient
43. Enterocytozoon bieneusi infection and diarrheal disease in patients who were not infected with human immunodeficiency virus: Case report and review
44. Microsporidia infection in transplant patients
45. A case of Enterocytozoon bieneusi infection in an HIV-negative renal transplant recipient
46. Risk factors for intestinal microsporidiosis in patients with human immunodeficiency virus infection: A case-control study
47. Improved light microscopical detection of microsporidia spores in stool and duodenal aspirates
48. Blinded, externally controlled multicenter evaluation of light microscopy and PCR for detection of microsporidia in stool specimens
49. Rapid epifluorescent technique to detect microsporidia
50. Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique
51. Application of molecular techniques to the diagnosis of microsporidial infection
52. Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy
53. Modification of the clinical course of intestinal microsporidiosis in acquired immunodeficiency syndrome patients by immune status and anti-human immunodeficiency virus therapy
54. Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS
55. Amebiasis
56. A redescription of Entamoeba histolytica Schaudinn 1903 (emended Walker 1911) separating it from Entamoeba dispar (Brumpt 1925)
57. Prevalence and immune response to Entamoeba histolytica infection in preschool children in Bangladesh
58. Association of serum antibodies to adherence lectin with invasive amebiasis and asymptomatic infection with pathogenic Entamoeba histolytica
59. Antibody response in intestinal and extraintestinal amebiasis
60. Cell-mediated immunity in patients with amebic abscess of the liver
61. Seroepidemiology of amebiasis in Mexico
62. Differentiation of pathogenic from nonpathogenic Entamoeba histolytica by restriction fragment analysis of a single gene amplified in vitro
63. Application of the polymerase chain reaction to the epidemiology of pathogenic and nonpathogenic Entamoeba histolytica
64. Direct amplification and differentiation of pathogenic and nonpathogenic Entamoeba histolytica DNA from stool specimens
65. An improved colorimetric PCR-based method for detection and differentiation of Entamoeba histolytica and Entamoeba dispar in feces
66. Simple differential detection of Entamoeba histelytica and Entamoeba dispar in fresh stool specimens by sodium acetate-acetic acid-formalin concentration and PCR
67. Diagnosis of amebic liver abscess and intestinal infection with the TechLab Entamoeba histolytica II antigen detection and antibody tests
68. A longitudinal study of asymptomatic carners of pathogenic zymodemes of Entamoeba histolytica
69. Amebiasis: Epidemiologic studies in the United States, 1971-1974
70. Amebiasis in a mental institution: Serologic and epidemiologic studies
71. Prevalence and clinical importance of Entamoeba histolytica in two high-risk groups; travelers returning from the tropics and male homosexuals
72. Entamoeba histolytica refection and AIDS
73. Etiologies of acute, persistent, and dysenteric diarrheas in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus